QUMAS Launches Highly Scalable Enterprise Compliance Solution for Microsoft SharePoint 2010
QUMAS, a provider of Compliance Solutions to highly regulated companies, announced the launch of its Enterprise Compliance Solution for Microsoft SharePoint 2010 at the 46th Annual Drug Information Association (DIA) Conference. The solution addresses all aspects of compliance content and process management, from Clinical through Regulatory, and on to Sales & Marketing, IT and Legal.
QUMAS' domain knowledge will now be available on a SharePoint 2010 platform.
"We have been approached by a number of firms that intend to make SharePoint 2010 a cornerstone of their technology infrastructure," said Kevin O'Leary, CEO QUMAS. " We recognize the game changing impact that SharePoint is having on the technology landscape. This is the single most exciting initiative we have undertaken in our 16 years of business and we are delighted to be working with Microsoft to deliver a compliance solution built entirely on the SharePoint 2010 platform."
The QUMAS Compliance Solution adds key solution-specific functionality that leverages and extends the underlying SharePoint platform to support industry demands in a number of key areas. These will include:
-Manufacturing Controlled Documents
-CAPA's and Deviations
-Clinical Trial Management
-Regulatory Documentation
-SOP Management (Policies and Procedures)
-Customer Complaints
-Change Control
-Policy Training and Certification
-R&D Document Control
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
